je.st
news
Cepheid gets FDA clearance to market Xpert Norovirus
2014-12-01 14:52:50| Apparel - Topix.net
Cepheid today announced it has received clearance from the U.S. Food & Drug Administration to market Xpert Norovirus, a qualitative in vitro diagnostic test for expeditious identification and differentiation of Noroviruses genogroup I and genogroup II . Both Xpert Norovirus and the recently cleared Xpert Flu/RSV XC have also been categorized as Moderate Complexity tests.
Tags: market
clearance
fda
norovirus
Category:Consumer Goods and Services